Recruiting at 1 site Phase 4 Tobacco

Clinical trial for Tobacco

Official title Combination Nicotine Replacement Therapy, Cytisine, or Varenicline for Smoking Cessation

ClinicalTrials.gov ID: NCT06832085

What this study is testing

What is Nicotine Replacement Therapy (Nicotine patch plus NRT gum or lozenge)?

This is an investigational combination of nicotine products being studied to help people quit smoking. It is designed to provide a steady level of nicotine to reduce withdrawal symptoms and cravings.

Also referred to as Nicotine Replacement Therapy gum, Nicotine Replacement Therapy lozenge.

Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
This study checks if people are willing to join a smoking quit program. It also tracks how safe and useful three types of quit products are when sent by mail.
Who it's for
Sun Life members who want to quit smoking.
What's involved
Participants will get smoking quit products and online coaching. Some people will only get coaching and fill out surveys.
Time commitment
The study lasts 12 months and includes regular check-ins.
  • Phase 4: studies an already-approved treatment

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Adults (≥18 years)
  • Current cigarette smokers (more than 5 cigarettes per day) who are interested in reducing or quitting in the next 6 months.
  • Able to provide informed consent.
  • Living in Ontario, Canada

You likely can't join if

  • Contraindications to any of the study medications (NRT, cytisine, varenicline).
  • Actively using one of the study medications in the past 7 days.
  • Actively enrolled in another formal smoking cessation program.
  • Pregnant or breastfeeding individuals.
  • Unable to engage in follow-up for any reason (for example an acute mental illness, cognitive impairment, unable to speak English or French).
  • Other conditions deemed by the study team to interfere with participation or outcomes in the opinion of the study investigator (for example acutely...

The study team makes the final eligibility decision.

Where it is enrolling

  • Ottawa, Ontario, Canada

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Ottawa, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.